medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2017, Number 6

<< Back Next >>

Salud Mental 2017; 40 (6)

Sociodemographic and clinical factors associated with dual disorders in a psychiatric hospital

Castaño PGA, Rojas BLA, Bareño SJ, Sierra HGM

Language: Spanish
References: 71
Page: 279-290
PDF size: 197.04 Kb.


ABSTRACT

Introduction. Among patients with mental illness, dual disorders patients are characterized by a heterogeneous and more severe clinical presentation that is difficult to treat. Therefore, knowledge about the distribution of this disorder and the characteristics of these patients can be helpful to optimize and organize health resources. Objective. To explore the prevalence and socio-demographic and clinical factors associated with dual disorders patients who were hospitalized due to mental illness at a psychiatric unit in Colombia between January and June 2013; this data was collected and analyzed on the basis of the medical records of each patient. Method. Observational, quantitative, cross-sectional study of a secondary source. It included the analysis of 201 patients aged 18 to 65. Results. There were 201 patients analyzed; 45.3% had dual disorders, with a ratio of 2.24 men:women; there was a high frequency of single marital status (69.2%) and more than 90% had a low socioeconomic level. The factors significantly associated with dual disorders in order of importance were: age from 18 to 35 years (OR = 11.03; CI 95% [4.43, 27.46]), male (OR = 5.10, CI 95% [2.26, 11.50]), history of aggression (OR = 3.35; CI 95% [1.63, 6.91]), and readmission in the year after hospital discharge (OR = 2.23; CI 95% [1.08, 4.61]). Discussion and conclusion. Dual disorders prevalence in this study is similar to that found by other authors. The high prevalence of dual disorders requires specialized therapeutic programs for treatment. The more hospitals know about the associated variables in this study, the more they will be able to improve their approach to patients.


REFERENCES

  1. Álvarez-Hernández, G., & Delgado-DelaMora, J. (2015). Diseño de Estudios Epidemiológicos. I. El Estudio Transversal: Tomando una Fotografía de la Salud y la Enfermedad. Boletín Clínico Hospital Infantil del Estado de Sonora, 32(1), 26-34.

  2. Appleby, L., Shaw, J., Amos, T., McDonnell, R., Harris, C., McCann, K., … & Parsons, R. (1999). Suicide within 12 months of contact with mental health services: national clinical survey. BMJ, 318(7193), 1235-1239.

  3. Arias, F., Szerman, N., Vega, P., Mesías, B., Basurte, I., Morant, C., … & Babín, F. (2013). Madrid study on the prevalence and characteristics of outpatients with dual pathology in community mental health and substance misuse services. Adicciones, 25(2), 118-127.

  4. Ball, D. C., Tornaría, M. L. G., del Arca, D., & Olson, D. H. (2013). Propiedades Psicométricas del FACES IV: Estudio de validez en población uruguaya. Ciencias Psicológicas, 7(2), 119-132.

  5. Barnaby, B., Drummond, C., McCloud, A., Burns, T., & Omu, N. (2003). Substance misuse in psychiatric inpatients: comparison of a screening questionnaire survey with case notes. BMJ, 327(7418), 783-784. doi: 10.1136/ bmj.327.7418.783

  6. Barrios-Ayola, F., & Hurtado-Acosta, A. (2012). Prevalencia del consumo compulsivo de alcohol y sustancias ilícitas en pacientes hospitalizados por patologías psiquiátricas. Revista Ciencias Biomédicas, 3(1), 69-76.

  7. Bertolote, J. M., & Sartorius, N. (1993). Clasificación de las enfermedades mentales: de Bertillon a la CIE-10, un siglo de colaboración internacional. Actas Luso-Españolas De Neurología, Psiquiatría Y Ciencias Afines, 21, 39-44.

  8. Brady, K., Casto, S., Lydiarcl, R. B., Malcolm, R., & Arana, G. (1991). Substance abuse in an inpatient psychiatric sample. The American Journal of Drug and Alcohol Abuse, 17(4), 389-397.

  9. Brown, E. S. (2005). Bipolar disorder and substance abuse. The Psychiatric Clinics of North America, 28(2), 415-425. doi: 10.1016/j.psc.2005.01.004

  10. Cantor-Graae, E., Nordström, L. G., & McNeil, T. F. (2001). Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophrenia Research, 48(1), 69-82.

  11. Cantwell, R., Brewin, J., Glazebrook, C., Dalkin, T., Fox, R., Medley, I., & Harrison, G. (1999). Prevalence of substance misuse in first-episode psychosis. The British Journal of Psychiatry, 174(2), 150-153.

  12. Carey, M. P., Carey, K. B., & Meisler, A. W. (1991). Psychiatric symptoms in mentally ill chemical abusers. The Journal of Nervous and Mental Disease, 179(3), 136-138.

  13. Casas, M. (2000). Trastornos duales. In J. Vallejo & C. Gastó (Eds.), Trastornos afectivos: ansiedad y depresión (pp. 890-900). Barcelona: Masson.

  14. Casas, M., Franco, M. D., Goikolea, J. M., Jiménez-Arriero, M. A., Martínez-Raga, J., Roncero, C., & Szerman, N. (2008). Bipolar disorder associated to substance use disorders (dual diagnosis). Systematic review of the scientific evidence and expert consensus. Actas Españolas de Psiquiatría, 36(6), 350-361.

  15. Castaño, G. A., & Sierra, G. M. (2016). Trastorno dual en población general de Itagüí, Colombia. Revista Colombiana de Psiquiatría, 45(2), 108-117. doi: 10.10167/j. rcp.2015.08.005

  16. Cogollo, Z., Gómez, E., de Arco, O., Ruíz, I., & Campo-Arias, A. (2009). Asociación entre disfuncionalidad familiar y síntomas depresivos con importancia clínica en estudiantes de Cartagena, Colombia. Revista Colombiana de Psiquiatría, 38(4), 637-644.

  17. Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64(5), 566-576. doi: 10.1001/archpsyc.64.5.566

  18. Comtois, K. A., Tisdall, W. A., Holdcraft, L. C., & Simpson, T. (2005). Dual diagnosis: impact of family history. The American Journal on Addictions, 14(3), 291-299. doi: 10.1080/10550490590949479

  19. Dervaux, A., Bayle, F. J., & Krebs, M.O. (2002). Substance misuse among people with schizophrenia: Similarities and differences between the UK and France. The British Journal of Psychiatry, 180(4), 381.

  20. Dickey, B., Normand, S. L. T., Weiss, R. D., Drake, R. E., & Azeni, H. (2002). Medical morbidity, mental illness, and substance use disorders. Psychiatric Services, 53(7), 861-867. doi: 10.1176/appi.ps.53.7.861

  21. DiNitto, D. M., Webb, D. K., & Rubin, A. (2002). Gender differences in dually-diagnosed clients receiving chemical dependency treatment. Journal of Psychoactive Drugs, 34(1), 105-117. doi: 10.1080/02791072.2002.10399942

  22. Drake, R. E., & Mueser, K. T. (2000). Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin, 26(1), 105-118.

  23. Drake, R. E., Mueser, K. T., Brunette, M. F., & McHugo, G. J. (2004). A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal, 27(4), 360-374.

  24. Driessen, M., Veltrup, C., Wetterling, T., John, U., & Dilling, H. (1998). Axis I and axis II comorbidity in alcohol dependence and the two types of alcoholism. Alcoholism, Clinical and Experimental Research, 22(1), 77-86.

  25. Dulit, R. A., Fyer, M. R., Haas, G. L., Sullivan, T., & Frances, A. J. (1990). Substance use in borderline personality disorder. The American Journal of Psychiatry, 147(8), 1002-1007.

  26. Farris, C., Brems, C., Johnson, M. E., Wells, R., Burns, R., & Kletti, N. (2003). A comparison of schizophrenic patients with or without coexisting substance use disorder. The Psychiatric Quarterly, 74(3), 205-222.

  27. Fenton, W. S. (2001). Comorbid conditions in schizophrenia. Current Opinion in Psychiatry, 14(1), 17-23.

  28. George, T. P., & Krystal, J. H. (2000). Comorbidity of psychiatric and substance abuse disorders. Current Opinion in Psychiatry, 13(3), 327-331.

  29. Giaconia, R. M., Reinherz, H. Z., Paradis, A. D., & Stashwick, C. K. (2003). Comorbidity of substance use disorders and posttraumatic stress disorder in a community sample of adolescents. In P. Ouimette & P. J. Brown (Eds.) Trauma and substance abuse: Causes, consequences, and treatment of comorbid disorders (pp. 227-242). Washington, DC: American Psychological Association.

  30. Gómez-Restrepo, C., & Okuda-Benavides, M. (2006). Metodología y lectura crítica de estudios Factores de confusión. Revista Colombiana de Psiquiatría, 35(2), 242-248.

  31. Gual, A. (2007). Dual diagnosis in Spain. Drug and Alcohol Review, 26(1), 65-71. doi: 10.1080/09595230601037000

  32. Hintz, T., & Mann, K. (2005). Comorbidity in alcohol use disorders: Focus on mood, anxiety and personality. In R. Stohler & W. Rössler (Eds.), Dual Diagnosis (pp. 65-91). Zürich: Karger.

  33. Hunt, G. E., Bergen, J., & Bashir, M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research, 54(3), 253-264.

  34. Jiménez-Castro, L., Raventós-Vorst, H., & Escamilla, M. (2011). Substance use disorder and schizophrenia: Prevalence and sociodemographic characteristics in the Latin American population. Actas Españolas De Psiquiatría, 39(2), 123- 130.

  35. Kamali, M., Kelly, L., Gervin, M., Browne, S., Larkin, C., & O’Callaghan, E. (2001). Psychopharmacology: insight and comorbid substance misuse and medication compliance among patients with schizophrenia. Psychiatric Services, 52(2), 161-163, 166. doi: 10.1176/appi.ps.52.2.161

  36. Karam, E. G., Yabroudi, P. F., & Melhem, N. M. (2002). Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon. Comprehensive Psychiatry, 43(6), 463-468. doi: 10.1053/ comp.2002.35910

  37. Koldobsky, N. M. (2010). Trastornos de Personalidad (TP) y Trastornos del Uso de Sustancias (TUS). Intersalud.

  38. Lehman, A. F., Myers, C. P., Corty, E., & Thompson, J. W. (1994). Prevalence and patterns of «dual diagnosis» among psychiatric inpatients. Comprehensive Psychiatry, 35(2), 106-112.

  39. Levin, F. R., & Hennessy, G. (2004). Bipolar disorder and substance abuse. Biological Psychiatry, 56(10), 738-748. doi: 10.1016/j.biopsych.2004.05.008

  40. López-Ibor, J. J., & Valdés, M., (2002). DSM-IV-TR: Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson.

  41. Manterola, C., & Pineda, V. (2008). El valor de” p” y la” significación estadística”: Aspectos generales y su valor en la práctica clínica. Revista chilena de cirugía, 60(1), 86-89.

  42. Margolese, H. C., Malchy, L., Negrete, J. C., Tempier, R., & Gill, K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research, 67(2-3), 157-166. doi: 10.1016/ S0920-9964(02)00523-6

  43. Marín-Navarrete, R., De la Fuente-Martín, A., Cano-Arrieta, G., Villalobos-Gallegos, L., Bucay-Harari, L., Larios-Chávez, L., & Ambriz-Figueroa, A. K. (2015). Mujeres con patología dual: características clínicas y de tratamiento. Revista Internacional de Investigación en Addicciones, 1(1), 41-49.

  44. McCrone, P., Menezes, P. R., Johnson, S., Scott, H., Thornicroft, G., Marshall, J., … & Kuipers, E. (2000). Service use and costs of people with dual diagnosis in South London. Acta Psychiatrica Scandinavica, 101(6), 464-472.

  45. McCrory, E. J., & Mayes, L. (2015). Understanding Addiction as a Developmental Disorder: An Argument for a Developmentally Informed Multilevel Approach. Current Addiction Reports, 2(4), 326-330. doi: 10.1007/s40429-015-0079-2

  46. McGrath, J. (2000). Universal interventions for the primary prevention of schizophrenia. The Australian and New Zealand Journal of Psychiatry, 34(2), 58-64. doi: 10.1080/000486700224

  47. Miquel, L., Roncero, C., López-Ortiz, C., & Casas, M. (2011). Epidemiological and diagnostic axis I gender differences in dual diagnosis patients. Adicciones, 23(2), 165-172.

  48. Mueser, K. T., Glynn, S. M., Cather, C., Zarate, R., Fox, L., Feldman, J., … & Clark, R. E. (2009). Family intervention for co-occurring substance use and severe psychiatric disorders: Participant characteristics and correlates of initial engagement and more extended exposure in a randomized controlled trial. Addictive Behaviors, 34(10), 867-877. doi: 10.1016/j.addbeh.2009.03.025

  49. Mueser, K. T., Yarnold, P. R., Rosenberg, S. D., Swett, C., Miles, K. M., & Hill, D. (2000). Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophrenia Bulletin, 26(1), 179-192.

  50. Olson, D. (2011). FACES IV and the Circumplex Model: validation study. Journal of Marital and Family Therapy, 37(1), 64-80. doi: 10.1111/j.1752- 0606.2009.00175.x

  51. Otto, M. W., Pollack, M. H., Sachs, G. S., O’Neil, C. A., & Rosenbaum, J. F. (1992). Alcohol dependence in panic disorder patients. Journal of Psychiatric Research, 26(1), 29-38.

  52. Patel, V., Chisholm, D., Parikh, R., Charlson, F. J., Degenhardt, L., Dua, T., … & Lund, C. (2015). Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. Lancet, 387(10028), 1672-1685. doi: 10.1016/S0140-6736(15)00390-6

  53. Peña-Salas, G. F., Bareño, J., Berbesí, D. Y., & Gaviria, S. L. (2014). Prevalencia de abuso y dependencia de alcohol en adultos con fobia social en Medellín. Revista Colombiana de Psiquiatría, 43(2), 66-72. doi: 10.1016/j.rcp.2013.11.011

  54. Pereiro, C., Pino, C., Flórez, G., Arrojo, M., Becoña, E., & COPSIAD Group. (2013). Psychiatric Comorbidity in Patients from the Addictive Disorders Assistance Units of Galicia: The COPSIAD Study. PloS One, 8(6), e66451. doi: 10.1371/ journal.pone.0066451

  55. Pettinati, H. M., O’Brien, C. P., & Dundon, W. D. (2013). Current status of co-occurring mood and substance use disorders: a new therapeutic target. The American Journal of Psychiatry, 170(1), 23-30. doi: 10.1176/appi.ajp.2012.12010112

  56. Primm, A. B., Gomez, M. B., Tzolova-Iontchev, I., Perry, W., Vu, H. T., & Crum, R. M. (2000). Mental health versus substance abuse treatment programs for dually diagnosed patients. Journal of Substance Abuse Treatment, 19(3), 285-290.

  57. Regier, D. A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., & Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 264(19), 2511-2518.

  58. Reissner, V., Kokkevi, A., Schifano, F., Room, R., Storbjörk, J., Stohler, R., … & Scherbaum, N. (2012). Differences in drug consumption, comorbidity and health service use of opioid addicts across six European urban regions (TREAT-project). European Psychiatry, 27(6), 455-462. doi: 10.1016/j.eurpsy.2010.10.001

  59. Rodríguez, R., Aragüéz, M., Jiménez, M., Ponce, G., Muñoz, A., Bagney, A., … & Palomo, T. (2008). Patología Dual en pacientes psiquiátricos hospitalizados: prevalencia y características generales. Investigación Clínica, 49(2), 195-205.

  60. Sanabria, M. A., Díaz, O., Varela, J., & Braña, T. (2002). Relevancia para el tratamiento de la sintomatología depresiva de los pacientes adictos. Adicciones, 14(1), 25-31.

  61. Seedat, S., Scott, K. M., Angermeyer, M. C., Berglund, P., Bromet, E. J., Brugha, T. S., … & Kessler, R. C. (2009). Cross-national associations between gender and mental disorders in the World Health Organization World Mental Health Surveys. Archives of General Psychiatry, 66(7), 785-795. doi: 10.1001/archgenpsychiatry. 2009.36

  62. Smilkstein, G. (1978). The family APGAR: a proposal for a family function test and its use by physicians. The Journal of Family Practice, 6(6), 1231-1239.

  63. Soyka, M. (2000). Substance misuse, psychiatric disorder and violent and disturbed behaviour. The British Journal of Psychiatry, 176(4), 345-350.

  64. Swendsen, J., Conway, K. P., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K. R., … & Kessler, R. C. (2010). Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction, 105(6), 1117-1128. doi: 10.1111/j.1360- 0443.2010.02902.x

  65. Swindle, R. W., Phibbs, C. S., Paradise, M. J., Recine, B. P., & Moos, R. H. (1995). Inpatient treatment for substance abuse patients with psychiatric disorders: a national study of determinants of readmission. Journal of Substance Abuse, 7(1), 79-97.

  66. Szerman, N., Martinez-Raga, J., Peris, L., Roncero, C., Basurte, I., Vega, P., … & Casas, M. (2013). Rethinking Dual Disorders/Pathology. Addictive Disorders & Their Treatment, 12(1), 1-10. doi: 10.1097/ADT.0b013e31826e7b6a

  67. Tómasson, K., & Vaglum, P. (1995). A nationwide representative sample of treatment- seeking alcoholics: a study of psychiatric comorbidity. Acta Psychiatrica Scandinavica, 92(5), 378-385.

  68. Torres, Y., Posada, J., Bareño, J., & Berbesí, D. Y. (2010). Substance use disorders in Colombia: Prevalence and comorbidity with other mental disorders. Revista Colombiana de Psiquiatría, 39(1), 105-136.

  69. Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., … & Paterson, S. (2003). Comorbidity of substance misuse and mental illness in community mental health and substance misuse services. The British Journal of Psychiatry, 183(4), 304-313.

  70. Woody, G. (1996). The challenge of dual diagnosis. Alcohol Research and Health, 20(2), 76.

  71. Zegarra-Valdivia, J. A., Chino, B. N., & Cazorla, E. (2016). Prevalencia de patología dual en el sur del Perú: estudio clínico-descriptivo. Interacciones. Revista de Avances en Psicología, 2(1), 11-19.




2020     |     www.medigraphic.com